Data Insights
Artificial Intelligence (10)
Big Data (4)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (2)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (3)
Showing 4 results out of 4
Q4 2023 update: cybersecurity related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that cybersecurity accounted for 2 pharmaceutical deals announced in Q4 2023,...
How did the pharmaceutical industry treat cybersecurity in Q4 2023 filings?
The global pharmaceutical industry experienced a 15% drop in company filings mentions of cybersecurity in Q4 2023 compared with the...
Q3 2023 update: cybersecurity related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 37% drop in new job postings related to cybersecurity in Q3 2023 compared with...
Hiring activity related to cybersecurity increased by 30% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 30% rise in new job postings related to cybersecurity in Q3 2022 compared with...